Clinical Trial

A Prospective, Observational Study to Evaluate the Safety and Feasibility of Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation in a Cohort Critical Ill Patients With Acute Kidney Injury and Presumed Absent Citrate Metabolism

Study acronym: CAT-RISK
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Use of regional citrate anticoagulation in an at risk population with decreased citrate metabolism. This study assesses the feasibility and safety of regional citrate anticoagulation in this population.
Trial Details
NCT Number NCT07751874
Lead Sponsor University Hospital, Antwerp
Conditions Acute Kidney Injury
Enrollment 50 participants
Start Date 2026-10-15
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-07